Expression of Copper-transporting P-type Adenosine Triphosphatase(ATP7B) in Human Hepatocellular Carcinoma

Anticancer Research

Volumn 24, Issue 2 C, 2004, Pages 1045-1048

  Sugeno, Hidekazu ^a   Takebayashi, Yuji ^a   Higashimoto, Masashi ^a,b   Ogura, Yoshito ^c   Shibukawa, Goro ^a   Kanzaki, Atsuko ^a   Terada, Kunihiko ^e   Sugiyama, Toshihiro ^e   Watanabe, Kumiko ^a   Katoh, Ryoji ^f   Nitta, Yasutaka ^d   Fukushima, Toshihiko ^a   Koyama, Yoshihisa ^a   Inoue, Norio ^a   Sekikawa, Kohji ^a   Ogawa, Kenji ^b   Sato, Yukio ^a   Takenoshita, Seiichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Minami Kyusyu Chuo National Hospital   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ATP7B; Cisplatin; Hepatocellular carcinoma

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CISPLATIN; COPPER; COPPER EXPORTING ADENOSINE TRIPHOSPHATASE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY;

ADENOSINE TRIPHOSPHATASES; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BILE DUCTS; CARCINOMA, HEPATOCELLULAR; CATION TRANSPORT PROTEINS; CISPLATIN; CYTOPLASMIC GRANULES; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 2442566926     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wingo PA, Tong T and Bolden S: Cancer statistics, 1995. CA Cancer J Clin 45: 8-30, 1995.
2. Boente MP, Schilder R and Ozols RF: Gynecologic cancers. Cancer Chemother Biol Response Modif 17: 536-61, 1997.
3. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J and Ling V: Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines, Nature 316: 817-9,1985.
4. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC and Scheper RJ: The drug resistance-related protein LRP is the human major vault protein. Nat Med 1: 578-82, 1995.
5. Ueda K, Cardarelli C, Gottesman MM and Pastan I: Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84: 3004-8, 1987.
6. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG: Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-10, 1994.
7. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM et al: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-24, 1989.
8. Nooter K, Bosman FT, Burger H, van Wingerden KE, Flens MJ, Scheper RJ, Oostrum RG, Boersma AW, van der Gaast A and Stoter G: Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol 7: 75-81, 1996.
9. Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B et al: Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res 59: 8-13, 1999.
10. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK et al: A multidrug resistance transporter from human MCF-7 breast cancer cells [published erratum appears in Proc Natl Acad Sci USA 96(5):2569, 1999]. Proc Natl Acad Sci USA 95: 15665-70, 1998.
11. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK et al: A multidrug resistance transporter from human MCF-7 breast cancer cells [published erratum appears in Proc Natl Acad Sci USA 96(5):2569, 1999]. Proc Natl Acad Sci USA 95: 15665-70, 1998.
12. Allen JD, Brinkhuis RF, Wijnholds J and Schinkel AH: The mouse Bcrp1/Mhr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res 59: 4237-41, 1999.
13. Volk EL, Rohde K, Rhee M, McGuire JJ, Doyle LA, Ross DD et al: Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux [In Process Citation]. Cancer Res 60: 3514-21, 2000.
14. Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T et al: Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res 60: 1312-6,2000.
15. Harris ED, Quian Y, Tiffany-Castiglioni E, Lacy AR and Reddy MC: Functional analysis of copper homeostasis in cell culture models: a new perspective on internal copper transport. Am J Clin Nutr 67 (Suppl.): 988S-95S, 1998.
16. Roberts EA and Cox DW: Wilson disease. Baillieres Clin Gastroenterol 12: 237-56,1998.
17. Terada K, Schilsky ML, Miura N and Sugiyama T: ATP7B (WND) protein. Int J Biochem Cell Biol 30: 1063-7, 1998.
18. Solioz M and Vulpe C: CPx-type ATPases: a class of P-type ATPases that pump heavy metals. Trends Biochem Sci 21: 237-41, 1996.
19. Gupta A, Matsui K, Lo JF and Silver S: Molecular basis for resistance to silver cations in Salmonella. Nat Med 5: 183-8, 1999.
20. Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH and Gilliam TC: Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 3: 1647-56, 1994.
21. Yang XL, Miura N, Kawarada Y, Terada K, Petrukhin K, Gilliam T et al: Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments. Biochem J 326: 897-902, 1997.